InVentiv Health Inc. (NASDAQ: VTIV), which provides commercialization services to the global healthcare industries, said Tuesday it acquired consulting company ParagonRx for an undisclosed amount.
ParagonRx specializes on pharmaceutical risk management plans.
Penny Stock Professor, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Penny Stock Picks.
The acquisition closed Dec. 31.
Shares of InVentiv fell 34 cents to $16.60 in afternoon trading.
Follow us on Twitter: http://www.twitter.com/pennystockspro
Sign up for the free Penny Stock Professor newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
About Us
Penny Stock Professor is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
